Loading...
XNYS
RMD
Market cap37bUSD
Jul 02, Last price  
255.88USD
1D
-0.15%
1Q
19.93%
Jan 2017
312.38%
Name

Resmed Inc

Chart & Performance

D1W1MN
P/E
36.75
P/S
8.01
EPS
6.96
Div Yield, %
0.58%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
12.44%
Revenues
4.69b
+10.95%
425,505,000606,996,000716,332,000835,397,000920,735,0001,092,357,0001,243,148,0001,368,515,0001,514,457,0001,554,973,0001,678,912,0001,838,713,0002,066,737,0002,340,196,0002,606,572,0002,957,013,0003,196,825,0003,578,127,0004,222,993,0004,685,297,000
Net income
1.02b
+13.75%
64,785,00088,211,00066,302,000110,303,000146,448,000190,085,000226,986,000254,850,000307,133,000345,273,000352,886,000352,408,000342,284,000315,588,000404,592,000621,674,000474,505,000779,437,000897,556,0001,020,951,000
CFO
1.40b
+102.11%
71,079,00099,028,00091,106,000137,836,000238,877,000188,213,000283,190,000383,159,000402,823,000391,268,000383,180,000547,932,000414,053,000505,026,000459,051,000802,255,000736,718,000351,147,000693,299,0001,401,260,000
Dividend
Aug 15, 20240.53 USD/sh
Earnings
Jul 30, 2025

Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
IPO date
Jun 01, 1995
Employees
10,140
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
4,685,297
10.95%
4,222,993
18.02%
Cost of revenue
2,337,519
2,154,973
Unusual Expense (Income)
NOPBT
2,347,778
2,068,020
NOPBT Margin
50.11%
48.97%
Operating Taxes
243,847
204,108
Tax Rate
10.39%
9.87%
NOPAT
2,103,931
1,863,912
Net income
1,020,951
13.75%
897,556
15.15%
Dividends
(282,320)
(258,276)
Dividend yield
1.00%
0.80%
Proceeds from repurchase of equity
(96,917)
49,142
BB yield
0.34%
-0.15%
Debt
Debt current
60,456
53,740
Long-term debt
1,005,479
1,686,859
Deferred revenue
137,343
119,186
Other long-term liabilities
42,257
105,349
Net debt
657,808
1,645,682
Cash flow
Cash from operating activities
1,401,260
693,299
CAPEX
(99,460)
(134,000)
Cash from investing activities
(269,784)
(1,159,845)
Cash from financing activities
(1,119,287)
422,874
FCF
2,201,290
1,321,467
Balance
Cash
238,361
227,891
Long term investments
169,766
(132,974)
Excess cash
173,862
Stockholders' equity
4,740,706
3,981,076
Invested Capital
5,768,994
5,956,265
ROIC
35.89%
36.05%
ROCE
38.99%
34.20%
EV
Common stock shares outstanding
147,550
147,455
Price
191.42
-12.39%
218.50
4.23%
Market cap
28,244,021
-12.34%
32,218,918
4.52%
EV
28,901,829
33,864,600
EBITDA
2,563,987
2,265,582
EV/EBITDA
11.27
14.95
Interest
45,708
47,379
Interest/NOPBT
1.95%
2.29%